Sackler Family Fortune Protected Under Purdue Pharma Bankruptcy Plan
Purdue Pharma has a bankruptcy plan that may ensure the Sackler family keeps their fortune.
Purdue, maker of the painkiller OxyContin, filed for Chapter 11 as it began the process of the settling several lawsuits, The Washington Post reported. The company asked the judge on Wednesday to temporarily pause the lawsuits racking up against the Sacklers, the family that owns it.
The Sacklers already agreed to a settlement with several states, which sued for their perpetuating role in the opioid crisis. If the judge doesn’t grant them protection, the company said the settlement deal may fall through.
State attorneys are incredulous, believing the Sacklers should be using their wealth — the state of Oregon believes they have taken about $10 billion out of the company, according to the Post — to combat the growing problem of opioid addiction.
Alyssa Fisher is a writer at the Forward. Email her at fisher@forward.com, or follow her on Twitter at @alyssalfisher
I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.
Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.
At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and the protests on college campuses.
Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.
Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly.
— Rachel Fishman Feddersen, Publisher and CEO
Join our mission to tell the Jewish story fully and fairly.